Harbor ETF Trust Harbor Multi-Asset Explorer ETF (MAPP) Covered Calls
The Company uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.
There are no covered calls available for Harbor ETF Trust Harbor Multi-Asset Explorer ETF.
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
MAP Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing new therapies to address undermet patient needs in neurology. The company is developing LEVADEX, which is an orally inhaled investigational drug for the acute treatment of migraine. It also applies its proprietary drug particle and inhalation technologies to generate new pipeline opportunities by enhancing the therapeutic benefits proven drugs. MAP Pharmaceuticals was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Mountain View, CA.
| Top 10 Open Interest For May 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | IWM covered calls | 6. | EEM covered calls | 1. | RIVN covered calls | |
| 2. | QQQ covered calls | 7. | TSLA covered calls | 2. | HIMS covered calls | |
| 3. | SPY covered calls | 8. | SLV covered calls | 3. | RDFN covered calls | |
| 4. | HYG covered calls | 9. | TLT covered calls | 4. | PCT covered calls | |
| 5. | FXI covered calls | 10. | NVDA covered calls | 5. | UPST covered calls | |
Want more examples? MANU Covered Calls | MAR Covered Calls
